Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients.
Mark R HanudelMarciana LasterGeorgina RamosBarbara GalesIsidro B SaluskyPublished in: Pediatric nephrology (Berlin, Germany) (2018)
In pediatric dialysis patients, ferric citrate may be able to concurrently lower phosphate levels and treat iron deficiency. However, larger studies are needed to further evaluate safety and efficacy in the pediatric chronic kidney disease population.